{"transactions":[{"id":2925394,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T21:51:39.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-21-000009","document":"form4-01042021_010119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000009/form4-01042021_010119.xml","form_type":"4"}},{"id":3169072,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T21:11:01.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-20-001068","document":"form4-04272020_050447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588920001068/form4-04272020_050447.xml","form_type":"4"}},{"id":3389706,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-22T21:01:55.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-19-001214","document":"form4-10222019_051035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919001214/form4-10222019_051035.xml","form_type":"4"}},{"id":3510179,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T20:10:32.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option reported herein shall vest on Vesting Start Date May 23, 2019, and 1/36th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":150000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-19-000585","document":"form4-05282019_010519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919000585/form4-05282019_010519.xml","form_type":"4"}},{"id":3828579,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:23:49.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":250000,"derivative":{"exercise_price":1.5,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001317","document":"form4-08312018_020834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001317/form4-08312018_020834.xml","form_type":"4"}},{"id":3828578,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:23:49.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests monthly over a period of three years commencing 4/26/2017."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2027-04-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-001317","document":"form4-08312018_020834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001317/form4-08312018_020834.xml","form_type":"4"}},{"id":3828577,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:23:49.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":40000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-18-001317","document":"form4-08312018_020834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001317/form4-08312018_020834.xml","form_type":"4"}},{"id":3828576,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:23:49.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests monthly over a period of three years commencing 11/9/2016."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2026-11-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-18-001317","document":"form4-08312018_020834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001317/form4-08312018_020834.xml","form_type":"4"}},{"id":3828575,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:23:49.000Z","date":"2018-08-29","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests monthly over a period of four years commencing 9/29/2016."}],"balance_after":125000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-18-001317","document":"form4-08312018_020834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001317/form4-08312018_020834.xml","form_type":"4"}},{"id":3828574,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-31T21:23:49.000Z","date":"2018-08-29","kind":"disposition_to_issuer","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person agreed to cancellation of an option granted to him on 9/29/2016 in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests monthly over a period of four years commencing 9/29/2016."}],"balance_after":0,"derivative":{"exercise_price":4.27,"expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-18-001317","document":"form4-08312018_020834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001317/form4-08312018_020834.xml","form_type":"4"}},{"id":3851845,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-06T20:53:48.000Z","date":"2018-08-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":150000,"derivative":{"exercise_price":1.27,"expiration_date":"2028-08-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-18-001226","document":"form4-08062018_010833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918001226/form4-08062018_010833.xml","form_type":"4"}},{"id":4076112,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":144227,"kind":"person","name":"MCPARTLAND MARK A.","position":1,"cik":"0001620140","reported_name":"MCPARTLAND MARK A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP CORPORATE DEVELOPMENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T21:57:20.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant February 2, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":150000,"derivative":{"exercise_price":1.16,"expiration_date":"2028-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-18-000190","document":"form4-02052018_010205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588918000190/form4-02052018_010205.xml","form_type":"4"}}]}